Strategies for long-term expression of transgenes in the respiratory epithelium

Current Opinion in Molecular Therapeutics

Volumn 12, Issue 4, 2010, Pages 386-393

  Gill, Deborah R ^a   Bazzani, Reto P ^a   Hyde, Stephen C ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOVIRUS VECTOR; ALPHA 1 ANTITRYPSIN; BETA GALACTOSIDASE; DNA; ELONGATION FACTOR 1ALPHA; GLYCOPROTEIN; INTERLEUKIN 10; LENTIVIRUS VECTOR; PARVOVIRUS VECTOR; PEPTIDE; PLASMID VECTOR; POLYETHYLENEIMINE; POLYMER; POLYUBIQUITIN; TOLL LIKE RECEPTOR 9; TRANSMEMBRANE CONDUCTANCE REGULATOR; VIRUS DNA;

ADENOVIRUS; BLOOD LEVEL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CLINICAL EFFECTIVENESS; CYSTIC FIBROSIS; ELECTROPORATION; ENDOSOME; EPITHELIUM; EPITHELIUM CELL; FELINE IMMUNODEFICIENCY VIRUS; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENE VECTOR; HOUSEKEEPING GENE; HUMAN; IMMUNE RESPONSE; ION TRANSPORT; LENTIVIRINAE; LUNG; NONHUMAN; NOSE; NOSE MUCOSA; PARAINFLUENZA VIRUS; PLASMID; PNEUMONIA; REPORTER GENE; RESPIRATORY EPITHELIUM; REVIEW; SENDAI VIRUS; STEM CELL; TRANSGENE; VIRAL GENE DELIVERY SYSTEM; ADENOVIRIDAE; ADMINISTRATION AND DOSAGE; ANIMAL; GENETICS; IMMUNOLOGY; METABOLISM; PROCEDURES; RESPIRATORY TRACT MUCOSA; TIME;

ADENOVIRIDAE; ANIMALS; GENE EXPRESSION; GENETIC THERAPY; GENETIC VECTORS; HUMANS; RESPIRATORY MUCOSA; TIME FACTORS; TRANSGENES;

EID: 77955409789     PISSN: 14648431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (63)

1. Rawlins EL, Hogan BL: Ciliated epithelial cell lifespan in the mouse trachea and lung. Am J Physiol Lung Cell Mol Physiol (2008) 295(1):L231-L234.
2. Kotton DN, Fine A: Lung stem cells. Cell Tissue Res (2008) 331(1):145-156.
3. Kim CF, Jackson EL, Woolfenden AE, Lawrence S, Babar I, Vogel S, Crowley D, Bronson RT, Jacks T: Identification of bronchioalveolar stem cells in normal lung and lung cancer. Cell (2005) 121(6):823-835.
4. Rock JR, Onaitis MW, Rawlins EL, Lu Y, Clark CP, Xue Y, Randell SH, Hogan BL: Basal cells as stem cells of the mouse trachea and human airway epithelium. Proc Natl Acad Sci USA (2009)106(31):12771-12775.
5. Harvey BG, Leopold PL, Hackett NR, Grasso TM, Williams PM, Tucker AL, Kaner RJ, Ferris B, Gonda I, Sweeney TD, Ramalingam R, et al.: Airway epithelial CFTR mRNA expression in cystic fibrosis patients after repetitive administration of arecombinant adenovirus. J Clin Invest (1999) 104(9):1245-1255.
6. Brunetti-Pierri N, Ng P: Progress towards the clinical application of helper-dependent adenoviral vectors for liver and lung gene therapy. Curr Opin Mol Ther (2006) 8(5):446-454.
7. Toietta G, Koehler DR, Finegold MJ, Lee B, Hu J, Beaudet AL: Reduced inflammation and improved airway expression using helper-dependent adenoviral vectors with a K18 promoter. Mol Ther (2003) 7(5 Pt 1):649-658.
8. Koehler DR, Frndova H, Leung K, Louca E, Palmer D, Ng P, McKerlie C, Cox P, Coates AL, Hu J: Aerosol delivery of an enhanced helper-dependent adenovirus formulation to rabbit lung using an intratracheal catheter. J Gene Med (2005) 7(11):1409-1420.
9. Koehler DR, Martin B, Corey M, Palmer D, Ng P, Tanswell AK, Hu J: Readministration of helper-dependent adenovirus to mouse lung. Gene Ther (2006) 13(9):773-780.
10. Kushwah R, Cao H, Hu J: Characterization of pulmonary T cell response to helper-dependent adenoviral vectors following intranasal delivery. J Immunol (2008) 180(6):4098-4108.
11. Cerullo V, Seiler MP, Mane V, Brunetti-Pierri N, Clarke C, Bertin TK, Rodgers JR, Lee B: Toll-like receptor 9 triggers an innate immune response to helper-dependent adenoviral vectors. Mol Ther (2007) 15(2):378-385.
12. Suzuki M, Cerullo V, Bertin TK, Cela R, Clarke C, Guenther M, Brunetti-Pierri N, Lee B: MyD88-dependent silencing of transgene expression during the innate and adaptive immune response to helper-dependent adenovirus. Hum Gene Ther (2010) 21(3):325-336.
13. Virella-Lowell I, Zusman B, Foust K, Loiler S, Conlon T, Song S, Chesnut KA, Ferkol T, Flotte TR: Enhancing rAAV vector expression in the lung. J Gene Med (2005) 7(7):842-850.
14. Zabner J, Seiler M, Walters R, Kotin RM, Fulgeras W, Davidson BL, Chiorini JA: Adeno-associated virus type 5 (AAV5) but not AAV2 binds to the apical surfaces of airway epithelia and facilitates gene transfer. J Virol (2000) 74(8):3852-3858.
15. Halbert CL, Allen JM, Miller AD: Adeno-associated virus type 6 (AAV6) vectors mediate efficient transduction of airway epithelial cells in mouse lungs compared to that of AAV2 vectors. J Virol (2001) 75(14):6615-6624.
16. Limberis MP, Wilson JM: Adeno-associated virus serotype 9 vectors transduce murine alveolar and nasal epithelia and can be readministered. Proc Natl Acad Sci USA (2006) 103(35):12993-12998.
17. Schnepp BC, Jensen RL, Chen CL, Johnson PR, Clark KR: Characterization of adeno-associated virus genomes isolated from human tissues. J Virol (2005) 79(23):14793-14803.
18. Sumner-Jones SG, Davies LA, Varathalingam A, Gill DR, Hyde SC: Long-term persistence of gene expression from adeno-associated virus serotype 5 in the mouse airways. Gene Ther (2006) 13(24):1703-1713.
19. Buff SM, Yu H, McCall JN, Caldwell SM, Ferkol TW, Flotte TR, Virella-Lowell IL: IL-10 delivery by AAV5 vector attenuates inflammation in mice with Pseudomonas pneumonia. Gene Ther (2010)17(5):567-576.
20. Liqun Wang R, McLaughlin T, Cossette T, Tang Q, Foust K, Campbell-Thompson M, Martino A, Cruz P, Loiler S, Mueller C, Flotte TR: Recombinant AAV serotype and capsid mutant comparison for pulmonary gene transfer of α-1-antitrypsin using invasive and noninvasive delivery. Mol Ther (2009) 17(1):81-87.
21. Liu X, Luo M, Guo C, Yan Z, Wang Y, Lei-Butters DC, Engelhardt JF: Analysis of adeno-associated virus progenitor cell transduction in mouse lung. Mol Ther (2009) 17(2):285-293.
22. Li W, Zhang L, Johnson JS, Zhijian W, Grieger JC, Ping-Jie X, Drouin LM, Agbandje-McKenna M, Pickles RJ, Samulski RJ: Generation of novel AAV variants by directed evolution for improved CFTR delivery to human ciliated airway epithelium. Mol Ther (2009) 17(12):2067-2077.
23. Limberis MP, Vandenberghe LH, Zhang L, Pickles RJ, Wilson JM: Transduction efficiencies of novel AAV vectors in mouse airway epithelium in vivo and human ciliated airway epithelium in vitro. Mol Ther (2009) 17(2):294-301.
24. Moss RB, Milla C, Colombo J, Accurso F, Zeitlin PL, Clancy JP, Spencer LT, Pilewski J, Waltz DA, Dorkin HL, Ferkol T, et al.: Repeated aerosolized AAV-CFTR for treatment of cystic fibrosis: A randomized placebo-controlled phase 2B trial. Hum Gene Ther (2007) 18(8):726-732.
25. Sumner-Jones SG, Gill DR, Hyde SC: Lack of repeat transduction by recombinant adeno-associated virus type 5/5 vectors in the mouse airway. J Virol (2007) 81(22): 12360-12367.
26. Zhu J, Huang X, Yang Y: The TLR9-MyD88 pathway is critical for adaptive immune responses to adeno-associated virus gene therapy vectors in mice. J Clin Invest (2009) 119(8): 2388-2398.
27. Halbert CL, Rutledge EA, Allen JM, Russell DW, Miller AD: Repeat transduction in the mouse lung by using adeno-associated virus vectors with different serotypes. J Virol (2000) 74(3): 1524-1532.
28. Limberis M, Anson DS, Fuller M, Parsons DW: Recovery of airway cystic fibrosis transmembrane conductance regulator function in mice with cystic fibrosis after single-dose lentivirus-mediated gene transfer. Hum Gene Ther (2002) 13(16):1961-1970.
29. Stocker AG, Kremer KL, Koldej R, Miller DS, Anson DS, Parsons DW: Single-dose lentiviral gene transfer for lifetime airway gene expression. J Gene Med (2009) 11(10):861-867.
30. Sinn PL, Burnight ER, Hickey MA, Blissard GW, McCray PB Jr: Persistent gene expression in mouse nasal epithelia following feline immunodeficiency virus-based vector gene transfer. J Virol (2005) 79(20):12818-12827.
31. Zhang L, Button B, Gabriel SE, Burkett S, Yan Y, Skiadopoulos MH, Dang YL, Vogel LN, McKay T, Mengos A, Boucher RC, et al.: CFTR delivery to 25% of surface epithelial cells restores normal rates of mucus transport to human cystic fibrosis airway epithelium. PLoS Biol (2009) 7(7):e1000155.
32. Kobayashi M, Iida A, Ueda Y, Hasegawa M: Pseudotyped lentivirus vectors derived from simian immunodeficiency virus SIVagm with envelope glycoproteins from paramyxovirus. J Virol (2003) 77(4):2607-2614.
33. Mitomo K, Griesenbach U, Inoue M, Somerton L, Meng C, Akiba E, Tabata T, Ueda Y, Frankel GM, Farley R, Singh C, et al.: Toward gene therapy for cystic fibrosis using a lentivirus pseudotyped with Sendai virus envelopes. Mol Ther (2010) 18(6):1173-1182.
34. Sinn PL, Arias AC, Brogden KA, McCray PB Jr: Lentivirus vector can be readministered to nasal epithelia without blocking immune responses. J Virol (2008) 82(21):10684-10692.
35. Hacein-Bey-Abina S, von Kalle C, Schmidt M, Le Deist F, Wulffraat N, McIntyre E, Radford I, Villeval JL, Fraser CC, Cavazzana-Calvo M, Fischer A: A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency. N Engl J Med (2003) 348(3):255-256.
36. Modlich U, Navarro S, Zychlinski D, Maetzig T, Knoess S, Brugman MH, Schambach A, Charrier S, Galy A, Thrasher AJ, Bueren J, et al.: Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gretroviral vectors. Mol Ther (2009) 17(11):1919-1928.
37. Montini E, Cesana D, Schmidt M, Sanvito F, Bartholomae CC, Ranzani M, Benedicenti F, Sergi LS, Ambrosi A, Ponzoni M, Doglioni C, et al.: The genotoxic potential of retroviral vectors is strongly modulated by vector design and integration site selection in a mouse model of HSC gene therapy. J Clin Invest (2009) 119(4):964-975.
38. Pringle IA, Hyde SC, Gill DR: Non-viral vectors in cystic fibrosis gene therapy: Recent developments and future prospects. Expert Opin Biol Ther (2009) 9(8):991-1003.
39. Hyde SC, Southern KW, Gileadi U, Fitzjohn EM, Mofford KA, Waddell BE, Gooi HC, Goddard CA, Hannavy K, Smyth SE, Egan JJ, et al.: Repeat administration of DNA/liposomes to the nasal epithelium of patients with cystic fibrosis. Gene Ther (2000) 7(13):1156-1165.
40. Ziady AG, Kelley TJ, Milliken E, Ferkol T, Davis PB: Functional evidence of CFTR gene transfer in nasal epithelium of cystic fibrosis mice in vivo following luminal application of DNA complexes targeted to the serpin-enzyme complex receptor. Mol Ther (2002) 5(4):413-419.
41. Alton EW, Stern M, Farley R, Jaffe A, Chadwick SL, Phillips J, Davies J, Smith SN, Browning J, Davies MG, Hodson ME, et al.: Cationic lipid-mediated CFTR gene transfer to the lungs and nose of patients with cystic fibrosis: A double-blind placebo-controlled trial. Lancet (1999) 353(9157):947-954.
42. Clinical programme. The UK Cystic Fibrosis Gene Therapy Consortium, London/Oxford/Edinburgh, UK (2010). www.cfgene therapy.org.uk/clinical- programme/clinical-programme1.4.htm
43. Dames P, Ortiz A, Schillinger U, Lesina E, Plank C, Rosenecker J, Rudolph C: Aerosol gene delivery to the murine lung is mouse strain dependent. J Mol Med (2007) 85(4):371-378.
44. Davies LA, McLachlan G, Sumner-Jones SG, Ferguson D, Baker A, Tennant P, Gordon C, Vrettou C, Baker E, Zhu J, Alton EW, et al.: Enhanced lung gene expression after aerosol delivery of concentrated pDNA/PEI complexes. Mol Ther (2008) 16(7):1283-1290.
45. Konstan MW, Davis PB, Wagener JS, Hilliard KA, Stern RC, Milgram LJ, Kowalczyk TH, Hyatt SL, Fink TL, Gedeon CR, Oette SM, et al.: Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution. Hum Gene Ther (2004) 15(12):1255-1269.
46. Pringle IA, Raman S, Sharp WW, Cheng SH, Hyde SC, Gill DR: Detection of plasmid DNA vectors following gene transfer to the murine airways. Gene Ther (2005) 12(15):1206-1214.
47. Pringle IA, McLachlan G, Collie DD, Sumner-Jones SG, Lawton AE, Tennant P, Baker A, Gordon C, Blundell R, Varathalingam A, Davies LA, et al.: Electroporation enhances reporter gene expression following delivery of naked plasmid DNA to the lung. J Gene Med (2007) 9(5):369-380.
48. Hyde SC, Pringle IA, Abdullah S, Lawton AE, Davies LA, Varathalingam A, Nunez-Alonso G, Green AM, Bazzani RP, Sumner-Jones SG, Chan M, et al.: CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression. Nat Biotechnol (2008) 26(5):549-551.
49. Argyros O, Wong SP, Niceta M, Waddington SN, Howe SJ, Coutelle C, Miller AD, Harbottle RP: Persistent episomal transgene expression in liver following delivery of a scaffold/matrix attachment region containing non-viral vector. Gene Ther (2008) 15(24):1593-1605.
50. Chen ZY, Riu E, He CY, Xu H, Kay MA: Silencing of episomal transgene expression in liver by plasmid bacterial backbone DNA is independent of CpG methylation. Mol Ther (2008) 16(3):548-556.
51. Mayrhofer P, Blaesen M, Schleef M, Jechlinger W. Minicircle-DNA production by site specific recombination and protein-DNA interaction chromatography. J Gene Med (2008) 10(11): 1253-1269.
52. Chen ZY, He CY, Ehrhardt A, Kay MA: Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo. Mol Ther (2003) 8(3):495-500.
53. Huang M, Chen Z, Hu S, Jia F, Li Z, Hoyt G, Robbins RC, Kay MA, Wu JC: Novel minicircle vector for gene therapy in murine myocardial infarction. Circulation (2009) 120(11 Suppl): S230-237.
54. Vaysse L, Gregory LG, Harbottle RP, Perouzel E, Tolmachov O, Coutelle C: Nuclear-targeted minicircle to enhance gene transfer with non-viral vectors in vitro and in vivo. J Gene Med (2006) 8(6):754-763.
55. Gill DR, Smyth SE, Goddard CA, Pringle IA, Higgins CF, Colledge WH, Hyde SC: Increased persistence of lung gene expression using plasmids containing the ubiquitin C or elongation factor 1α promoter. Gene Ther (2001) 8(20): 1539-1546.
56. Belur LR, Podetz-Pedersen K, Frandsen J, McIvor RS. Lung-directed gene therapy in mice using the nonviral Sleeping Beauty transposon system. Nat Protoc (2007) 2(12):3146-3152.
57. Saridey SK, Liu L, Doherty JE, Kaja A, Galvan DL, Fletcher BS, Wilson MH: PiggyBac transposon-based inducible gene expression in vivo after somatic cell gene transfer. Mol Ther (2009) 17(12):2115-2120.
58. Aneja MK, Imker R, Rudolph C: Phage φC31 integrasemediated genomic integration and long-term gene expression in the lung after nonviral gene delivery. J Gene Med (2007) 9(11):967-975.
59. Lawton AE, Pringle IA, Davies LA, Hyde SC, Gill DR: Non-viral integrating vectors for the lung: Sleeping beauty transposons. Mol Ther (2002) 5(5):S323.
60. Yew NS, Zhao H, Wu IH, Song A, Tousignant JD, Przybylska M, Cheng SH: Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs. Mol Ther (2000) 1(3):255-262.
61. Ruiz FE, Clancy JP, Perricone MA, Bebok Z, Hong JS, Cheng SH, Meeker DP, Young KR, Schoumacher RA, Weatherly MR, Wing L, et al.: A clinical inflammatory syndrome attributable to aerosolized lipid-DNA administration in cystic fibrosis. Hum Gene Ther (2001) 12(7):751-761.
62. Reyes-Sandoval A, Ertl HC: CpG methylation of a plasmid vector results in extended transgene product expression by circumventing induction of immune responses. Mol Ther (2004) 9(2):249-261.
63. Lesina E, Dames P, Flemmer A, Hajek K, Kirchner T, Bittmann I, Rudolph C: CpG-free plasmid DNA prevents deterioration of pulmonary function in mice. Eur J Pharm Biopharm (2010) 74(3):427-434.